242 related articles for article (PubMed ID: 7594773)
1. Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.
Oosterwijk C; Höppener JW; van Hulst KL; Lips CJ
Int J Pancreatol; 1995 Aug; 18(1):7-14. PubMed ID: 7594773
[TBL] [Abstract][Full Text] [Related]
2. Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice.
Höppener JW; Oosterwijk C; van Hulst KL; Verbeek JS; Capel PJ; de Koning EJ; Clark A; Jansz HS; Lips CJ
J Cell Biochem; 1994; 55 Suppl():39-53. PubMed ID: 7929617
[TBL] [Abstract][Full Text] [Related]
3. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
O'Brien TD; Butler PC; Westermark P; Johnson KH
Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
[TBL] [Abstract][Full Text] [Related]
4. Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin.
Yagui K; Yamaguchi T; Kanatsuka A; Shimada F; Huang CI; Tokuyama Y; Ohsawa H; Yamamura K; Miyazaki J; Mikata A
Eur J Endocrinol; 1995 Apr; 132(4):487-96. PubMed ID: 7711888
[TBL] [Abstract][Full Text] [Related]
5. [Role of IAPP in the pathogenesis and development of NIDDM].
Sanke T; Nishi M; Nanjo K
Nihon Rinsho; 1994 Oct; 52(10):2737-45. PubMed ID: 7983807
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson J; Soeller WC; Roche PC; Nelson RT; Torchia AJ; Kreutter DK; Butler PC
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7283-8. PubMed ID: 8692984
[TBL] [Abstract][Full Text] [Related]
7. Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans.
de Koning EJ; Höppener JW; Verbeek JS; Oosterwijk C; van Hulst KL; Baker CA; Lips CJ; Morris JF; Clark A
Diabetes; 1994 May; 43(5):640-4. PubMed ID: 8168639
[TBL] [Abstract][Full Text] [Related]
8. [Construction of transgenic mouse system expressing human islet amyloid polypeptide (IAPP)/amylin].
Yagui K; Kanatsuka A; Makino H
Nihon Rinsho; 1994 Oct; 52(10):2746-50. PubMed ID: 7983808
[TBL] [Abstract][Full Text] [Related]
9. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
[TBL] [Abstract][Full Text] [Related]
10. Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic beta cells.
Tokuyama T; Yagui K; Yamaguchi T; Huang CI; Kuramoto N; Shimada F; Miyazaki J; Horie H; Saito Y; Makino H; Kanatsuka A
Metabolism; 1997 Sep; 46(9):1044-51. PubMed ID: 9284894
[TBL] [Abstract][Full Text] [Related]
11. Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM).
Fox N; Schrementi J; Nishi M; Ohagi S; Chan SJ; Heisserman JA; Westermark GT; Leckström A; Westermark P; Steiner DF
FEBS Lett; 1993 May; 323(1-2):40-4. PubMed ID: 8495745
[TBL] [Abstract][Full Text] [Related]
12. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
Jeong HR; An SS
Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
[TBL] [Abstract][Full Text] [Related]
13. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.
Verchere CB; D'Alessio DA; Palmiter RD; Weir GC; Bonner-Weir S; Baskin DG; Kahn SE
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3492-6. PubMed ID: 8622964
[TBL] [Abstract][Full Text] [Related]
14. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
Westermark P
Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
[TBL] [Abstract][Full Text] [Related]
15. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.
Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S
Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Kahn SE; Andrikopoulos S; Verchere CB
Diabetes; 1999 Feb; 48(2):241-53. PubMed ID: 10334297
[TBL] [Abstract][Full Text] [Related]
17. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes.
Matveyenko AV; Butler PC
ILAR J; 2006; 47(3):225-33. PubMed ID: 16804197
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
[TBL] [Abstract][Full Text] [Related]
19. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.
de Koning EJ; Morris ER; Hofhuis FM; Posthuma G; Höppener JW; Morris JF; Capel PJ; Clark A; Verbeek JS
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8467-71. PubMed ID: 8078905
[TBL] [Abstract][Full Text] [Related]
20. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
Jaikaran ET; Clark A
Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
